Back
Global X Nasdaq 100® Covered Call&Gr ETF Vs. Tandem Diabetes Care Industry Stock Comparison
Buy
80
QYLG
Global X Nasdaq 100® Covered Call&Gr ETF
Last Price:
30.61
Seasonality Move:
6.45%
Buy
75
TNDM
Tandem Diabetes Care
Last Price:
49.35
Seasonality Move:
17.33%
Buy
80
Global X Nasdaq 100® Covered Call&Gr ETF (QYLG)
is a Buy
Is Global X Nasdaq 100® Covered Call&Gr ETF a Buy, Sell or Hold?
- The current Global X Nasdaq 100® Covered Call&Gr ETF [QYLG] share price is $30.63. The Score for QYLG is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- QYLG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Tandem Diabetes Care (TNDM)
is a Buy
Is Tandem Diabetes Care a Buy, Sell or Hold?
- The current Tandem Diabetes Care [TNDM] share price is $49.32. The Score for TNDM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- TNDM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QYLG Stock Price Chart
What is Global X Nasdaq 100® Covered Call&Gr ETF's stock price today?
-
The Global X Nasdaq 100® Covered Call&Gr ETF share price today is $30.63
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QYLG is experiencing buying pressure, which is a positive indicator for future bullish movement.
TNDM Stock Price Chart
What is Tandem Diabetes Care's stock price today?
-
The Tandem Diabetes Care share price today is $49.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNDM is experiencing selling pressure, which indicates risk of future bearish movement.
QYLG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 62.31 | Buy |
| Chaikin Money Flow: | 15641 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.43 - 30.43) | Buy |
| Bollinger Bands (100): | (29.31 - 30.55) | Buy |
TNDM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Sell |
| Relative Strength Index (14 RSI): | 76.06 | Buy |
| Chaikin Money Flow: | -2987513 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
QYLG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.5 | Buy |
| 20-day SMA: | 30.08 | Buy |
| 50-day SMA: | 30.18 | Buy |
| 200-day SMA: | 28.65 | Buy |
| 8-day EMA: | 30.48 | Buy |
| 20-day EMA: | 30.25 | Buy |
| 50-day EMA: | 30.1 | Buy |
| 200-day EMA: | 28.86 | Buy |
TNDM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0 | Buy |
| 20-day SMA: | 0 | Buy |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 0 | Buy |
| 20-day EMA: | 0 | Buy |
| 50-day EMA: | 0 | Buy |
| 200-day EMA: | 0 | Buy |
Global X Nasdaq 100® Covered Call&Gr ETF Earnings Growth & QYLG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.15 per share, and an increase next year of $0.54 per share.
Global X Nasdaq 100® Covered Call&Gr ETF Technical Analysis
| May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tandem Diabetes Care Technical Analysis
| May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||